Detalhe da pesquisa
1.
Susceptibility testing breakpoints for Mycobacterium tuberculosis categorize isolates with resistance mutations in gyrA as susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TB.
J Antimicrob Chemother
; 71(2): 333-8, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26538509
2.
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study.
Eur Respir J
; 42(6): 1604-13, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23598956
3.
Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis.
Bull World Health Organ
; 90(9): 693-8, 2012 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22984314
4.
[Jaundice in the adult patient]. / ABC om Ikterus hos vuxna.
Lakartidningen
; 1192022 12 05.
Artigo
em Sueco
| MEDLINE | ID: mdl-36465003
5.
Stockholm score of lesion detection on computed tomography following mild traumatic brain injury (SELECT-TBI): study protocol for a multicentre, retrospective, observational cohort study.
BMJ Open
; 12(9): e060679, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36581962
6.
CD4+ T cell proliferative responses to PPD and CFP-10 associate with recent M. tuberculosis infection.
Tuberculosis (Edinb)
; 123: 101959, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32741535
7.
Phylogenetically informative mutations in genes implicated in antibiotic resistance in Mycobacterium tuberculosis complex.
Genome Med
; 12(1): 27, 2020 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32143680
8.
Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis.
J Antimicrob Chemother
; 64(4): 786-93, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19633001
9.
The nitrate reductase assay for the rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis.
J Antimicrob Chemother
; 62(1): 56-64, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18407918
10.
Wild-type MIC distributions must be considered to set clinically meaningful susceptibility testing breakpoints for all bacterial pathogens, including Mycobacterium tuberculosis.
Antimicrob Agents Chemother
; 55(9): 4492-3; author reply 4493, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21849570
11.
A luciferase-based assay for rapid assessment of drug activity against Mycobacterium tuberculosis including monitoring of macrophage viability.
J Microbiol Methods
; 106: 146-150, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25194234
12.
A 24-well plate assay for simultaneous testing of first and second line drugs against Mycobacterium tuberculosis in a high endemic setting.
BMC Res Notes
; 7: 512, 2014 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25108648
13.
The GenoType® MTBDRplus assay for detection of drug resistance in Mycobacterium tuberculosis in Sweden.
APMIS
; 120(5): 405-9, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22515295
14.
Tentative susceptibility testing breakpoint for the neuroleptic drug thioridazine, a treatment option for multi- and extensively drug resistant tuberculosis.
Int J Mycobacteriol
; 1(4): 177-9, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26785619
15.
Resistance to first-line anti-TB drugs is associated with reduced nitric oxide susceptibility in Mycobacterium tuberculosis.
PLoS One
; 7(6): e39891, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22768155
16.
Antioxidants protect keratinocytes against M. ulcerans mycolactone cytotoxicity.
PLoS One
; 5(11): e13839, 2010 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-21079804
17.
Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis
Bull. W.H.O. (Print)
; 90(9): 693-698, 2012-9-01.
Artigo
em Inglês
| WHOLIS | ID: who-271190